Aimmune Therapeutics, Inc (AIMT) Covered Calls

Aimmune Therapeutics Inc is a clinical-stage biopharmaceutical company advancing a new therapeutic approach, including the development of proprietary product candidates, for the treatment of peanut and other food allergies.

You can sell covered calls on Aimmune Therapeutics, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for AIMT (prices last updated Wed 4:16 PM ET):

Aimmune Therapeutics, Inc (AIMT) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
23.20 +0.20 22.75 23.78 542K - 1.4B
Covered Calls For Aimmune Therapeutics, Inc (AIMT)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Mar 15 22.5 1.80 21.98 2.4% 36.5%
Apr 18 22.5 2.65 21.13 6.5% 40.9%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company which engages in the research and development of desensitization treatments for allergies. Its portfolio includes the characterized oral desensitization immunotherapy (CODIT) system. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA.